We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current ENDV market cap is 158.73k. The company's latest EPS is USD 0.0175 and P/E is 0.00.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 310k | 166k | 73k | 135k | 140k |
| Operating Income | -3.81M | -2.91M | -2.23M | -3.27M | -2.92M |
| Net Income | -17.32M | -396k | -3.11M | -18.48M | 6.93M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 3.28M | 2.61M | 2.01M | 1.28M | 638k |
| Total Liabilities | 21.97M | 16.98M | 17.78M | 33.46M | 24.75M |
| Total Equity | -20.5M | -14.37M | -15.77M | -32.18M | -24.11M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -2.54M | -742k | -987k | -679k | 122k |
| Investing | -3k | N/A | N/A | N/A | N/A |
| Financing | 2.18M | 736k | 1.06M | 593k | -120k |
| Market Cap | 158.73k |
| Price to Earnings Ratio | 0.00 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 396.83M |
| Average Volume (1 week) | 43.06M |
| Average Volume (1 Month) | 21.89M |
| 52 Week Change | -95.29% |
| 52 Week High | 0.012 |
| 52 Week Low | 0.00035 |
| Spread (Intraday) | 0 (14.29%) |
| Company Name | Endonovo Therapeutics Inc (PK) |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.endonovo.com |
| Industry | electromedical apparatus (3845) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
